SlideShare a Scribd company logo
1 of 54
Connecting Precision Medicine
to Precision Wellness towards a
systems understanding of
health and disease
Joel Dudley, PhD
Director of Biomedical Informatics &
Associate Professor of Genetics and Genomic
Sciences, Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at
Mount Sinai @IcahnInstitute
Mount Sinai Health System
>6,000
Physicians
7
Member hospital campuses
>3,500
>3,100,000
Patient visits
Hospital beds
“The future is already here — it's
just not very evenly distributed”.
- William Gibson
There are rarely smoking guns in
human health
There are rarely smoking guns in
human health
No such thing as a “simple” disease
Cutting GR. Nature Reviews Genetics. (2014) doi:10.1038/nrg3849
Woody Guthrie
Complex molecular networks underlie
human physiology
We must embrace complexity to fully
understand patient physiology and disease
“A complex adaptive system has three characteristics.
The first is that the system consists of a number of
heterogeneous agents, and each of those agents makes
decisions about how to behave. The most important
dimension here is that those decisions will evolve over
time. The second characteristic is that the agents
interact with one another. That interaction leads to the
third—something that scientists call emergence: In a
very real way, the whole becomes greater than the sum
of the parts. The key issue is that you can’t really
understand the whole system by simply looking at its
individual parts”.
- Michael J. Mauboussin (investment banker)
Icahn Institute for Genomics and Multiscale Biology
Being masters of really big data is now critical
for biomedical research (TB→PB→EB→ZB)
Organisms Tissues Single cells
Single cell,
real-time,
continuous?
Biology’s atom smasher moment— We can
measure more than we know
Redefining the system of human disease with data
~300 Diseases
and Conditions
20k+ Genes
Blue: gene goes
down in disease
Yellow: gene goes up
in disease
Redefining the system of human disease with data
Suthram S, Dudley J et al. Network-based elucidation of human disease similarities reveals common functional
modules enriched for pluripotent drug targets. PLoS Computational Biology (2010)
Figure 2. Significant disease-disease similarities. (A)Hierarchical clustering of thediseasecorrelations.Thedistancebetweentwo disease
defined to be(1-correlation coefficient) of thetwo diseases. Thetree wasconstructed using theaverage method of hierarchical clustering. Th
line corresponds to a p-value of 0.01 and FDRof 10.37%and, disease correlations below this line are considered significant. The different c
Unexpected connection: anticonvulsant drug treats
inflammatory bowel disease
• TNBS chemically
induced rat model of
IBD
• Animals treated with
80mg/kg topiramate
oral after
sensitization
• Prednisolone positive
control (approved for
IBD in humans)
Dudley, J. T., Sirota, M., et al. (2011). Computational Repositioning of the Anticonvulsant Topiramate for
Inflammatory Bowel Disease. Science Translational Medicine, 3(96).
Control Imipramine
Unexpected connection: antipsychotic drug treats small cell
lung cancer
p53/Rb/p130
triple knockout
model of SCLC
Mice dosed
after
tumor
formation
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015)
Nature Biotechnology. in press.
How do approved drugs modulate networks
in immune cells?
Antifungal activates neutrophil migration
Drug A
Drug B
Drug A
Drug A Drug B
Drug A Drug B
Drug A Drug B
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of
immune pharmacology. (2015) Nature Biotechnology. in press.
Antifungal activates neutrophil migration
Drug A
Drug B
Drug A
Drug A Drug B
Drug A Drug B
Drug A Drug B
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative
analysis of immune pharmacology. (2015) Nature Biotechnology. in press.
Immunemod score predicts immune cell
perturbations in patient populations
Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015)
Nature Biotechnology. in press.
Understanding the multiscale complexity of
patient populations
=
Genomic
Environment
Clinical
Capturing rich multi scale data on patients
through the Mount Sinai Biobank
Image credit:
Li Li (ISMMS)
Type 2, Type 3, and Type 4 diabetes?
200
Data Feeds
5Gb
Data/lap
300
Sensors
3,000
Variables/0.1 sec
>200Gb
Data/day
We are on the crest of a tsunami in consumer
sensor technologies
Printable tattoo biosensor
Genome function is very context dependent
• eQTL
• What?
• Where?
• When?
Genome function is all about
context
Genome function is all about context
1. Drug A
2. Drug B
3. Drug C
4. Tolfenamic Acid
5. Drug D
6. Drug E
7. …
SP1
NDMN Network Model
Drugs perturbing SP1 sub-
network towards healthy
prioritized by network activity
The network as the target
Web-scale deep computing as the future of
medicine and research
http://www.bbc.com/news/technology-18595351
Web-scale deep computing as the future of
medicine and research
Xiong et al. Science 9 January 2015
Consumer health
tools as a driver
of data-driven
healthcare
Where will most
of the health
data be in 5-10
years?
We can embrace digital health and sensors to map the
human phoneme and envirome
Electronic Consent and Patient Engagement
Electronic Consent and Patient Engagement
A Learning Digital Health Platform for Chronic
Lung Disease
A Learning Digital Health Platform for Chronic
Lung Disease
We need to collect “long” dynamic data
for Precision Wellness
In the future you will have coordinates instead of a diagnosis
Topol EJ. Individualized Medicine from Prewomb to Tomb Cell 157, March 27, 2014
The emergence of science- and data-driven wellness
info@precisionwellness.org
The emergence of science- and data-driven wellness
info@precisionwellness.org
Digital Health
Molecular Profiling
Data Science
Clinical Medicine
The Harris Center for Precision Wellness
www.precisionwellness.org
“The future is already here — it's
just not very evenly distributed”.
- William Gibson
Email: joel.dudley@mssm.edu
Twitter: @jdudley
Web: dudleylab.org
precisionwellness.org
Icahn School of Medicine at
Mount Sinai
Thank you for your attention!

More Related Content

What's hot

Question of Quality Conference 2016 - Jonathan B. Perlin
Question of Quality Conference 2016 - Jonathan B. PerlinQuestion of Quality Conference 2016 - Jonathan B. Perlin
Question of Quality Conference 2016 - Jonathan B. PerlinHCA Healthcare UK
 
Personalized Medicine in Oncology
Personalized Medicine in OncologyPersonalized Medicine in Oncology
Personalized Medicine in OncologyBita Fakhri
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Warren Kibbe
 
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...Cancer Treatment Centers of America
 
Computational challenges in precision medicine and genomics
Computational challenges in precision medicine and genomicsComputational challenges in precision medicine and genomics
Computational challenges in precision medicine and genomicsGary Bader
 
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineQuestion of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineHCA Healthcare UK
 
Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Maryam Rafati
 
Cancer moonshot and data sharing
Cancer moonshot and data sharingCancer moonshot and data sharing
Cancer moonshot and data sharingWarren Kibbe
 
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud PilotsC-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud PilotsWarren Kibbe
 
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...Cancer Treatment Centers of America
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...Dexter Hadley
 
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meeting
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meetingDay 2 Big Data panel at the NIH BD2K All Hands 2016 meeting
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meetingWarren Kibbe
 
The evolving promise of genomic medicine ibm white paper
The evolving promise of genomic medicine ibm white paperThe evolving promise of genomic medicine ibm white paper
The evolving promise of genomic medicine ibm white paperPietro Leo
 
SuperComputing 16 HPC Matters Panel on Precision Medicine
SuperComputing 16 HPC Matters Panel on Precision MedicineSuperComputing 16 HPC Matters Panel on Precision Medicine
SuperComputing 16 HPC Matters Panel on Precision MedicineWarren Kibbe
 
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer Moonshot
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer MoonshotPrecision Medicine in the Age of NCI MATCH and the Beau Biden Cancer Moonshot
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer MoonshotWarren Kibbe
 
Genomics and Computation in Precision Medicine March 2017
Genomics and Computation in Precision Medicine March 2017Genomics and Computation in Precision Medicine March 2017
Genomics and Computation in Precision Medicine March 2017Warren Kibbe
 
#HCAQofQ Sir Liam Donaldson
#HCAQofQ Sir Liam Donaldson#HCAQofQ Sir Liam Donaldson
#HCAQofQ Sir Liam DonaldsonRebecca Pullen
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and MedicineWarren Kibbe
 

What's hot (19)

Informing treatment decisions for women with DCIS
Informing treatment decisions for women with DCISInforming treatment decisions for women with DCIS
Informing treatment decisions for women with DCIS
 
Question of Quality Conference 2016 - Jonathan B. Perlin
Question of Quality Conference 2016 - Jonathan B. PerlinQuestion of Quality Conference 2016 - Jonathan B. Perlin
Question of Quality Conference 2016 - Jonathan B. Perlin
 
Personalized Medicine in Oncology
Personalized Medicine in OncologyPersonalized Medicine in Oncology
Personalized Medicine in Oncology
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
 
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO  Chief, Department of S...
Cancer Prevention-- Robert A. Wascher, MD, FACS, FSSO Chief, Department of S...
 
Computational challenges in precision medicine and genomics
Computational challenges in precision medicine and genomicsComputational challenges in precision medicine and genomics
Computational challenges in precision medicine and genomics
 
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineQuestion of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer Medicine
 
Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer
 
Cancer moonshot and data sharing
Cancer moonshot and data sharingCancer moonshot and data sharing
Cancer moonshot and data sharing
 
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud PilotsC-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
C-Change Cancer Big Data, NCI Genomic Data Commons, Cloud Pilots
 
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
Advances in Personalized Medicine and Improving the Quality of Life: The Futu...
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
 
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meeting
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meetingDay 2 Big Data panel at the NIH BD2K All Hands 2016 meeting
Day 2 Big Data panel at the NIH BD2K All Hands 2016 meeting
 
The evolving promise of genomic medicine ibm white paper
The evolving promise of genomic medicine ibm white paperThe evolving promise of genomic medicine ibm white paper
The evolving promise of genomic medicine ibm white paper
 
SuperComputing 16 HPC Matters Panel on Precision Medicine
SuperComputing 16 HPC Matters Panel on Precision MedicineSuperComputing 16 HPC Matters Panel on Precision Medicine
SuperComputing 16 HPC Matters Panel on Precision Medicine
 
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer Moonshot
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer MoonshotPrecision Medicine in the Age of NCI MATCH and the Beau Biden Cancer Moonshot
Precision Medicine in the Age of NCI MATCH and the Beau Biden Cancer Moonshot
 
Genomics and Computation in Precision Medicine March 2017
Genomics and Computation in Precision Medicine March 2017Genomics and Computation in Precision Medicine March 2017
Genomics and Computation in Precision Medicine March 2017
 
#HCAQofQ Sir Liam Donaldson
#HCAQofQ Sir Liam Donaldson#HCAQofQ Sir Liam Donaldson
#HCAQofQ Sir Liam Donaldson
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
 

Viewers also liked

SILS 2015 - Transforming Data into Actionable Knowledge
SILS 2015 - Transforming Data into Actionable KnowledgeSILS 2015 - Transforming Data into Actionable Knowledge
SILS 2015 - Transforming Data into Actionable KnowledgeSherbrooke Innopole
 
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
 
RVTIC 2017: Portrait de la main d'oeuvre en TI
RVTIC 2017: Portrait de la main d'oeuvre en TIRVTIC 2017: Portrait de la main d'oeuvre en TI
RVTIC 2017: Portrait de la main d'oeuvre en TISherbrooke Innopole
 
RVTIC 2017: Prendre le virage numérique...maintenant!
RVTIC 2017: Prendre le virage numérique...maintenant!RVTIC 2017: Prendre le virage numérique...maintenant!
RVTIC 2017: Prendre le virage numérique...maintenant!Sherbrooke Innopole
 
SILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSherbrooke Innopole
 
Capital intellectuel – Votre entreprise est assise sur une mine d’or
Capital intellectuel – Votre entreprise est assise sur une mine d’or Capital intellectuel – Votre entreprise est assise sur une mine d’or
Capital intellectuel – Votre entreprise est assise sur une mine d’or Sherbrooke Innopole
 
Demande de certificat d’autorisation (C.A.) MDDELCC
Demande de certificat d’autorisation (C.A.) MDDELCCDemande de certificat d’autorisation (C.A.) MDDELCC
Demande de certificat d’autorisation (C.A.) MDDELCCSherbrooke Innopole
 
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?Sherbrooke Innopole
 
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...Sherbrooke Innopole
 
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif Terre
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif TerreRVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif Terre
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif TerreSherbrooke Innopole
 
Stephen Friend PRISME Forum 2011-05-04
Stephen Friend PRISME Forum 2011-05-04Stephen Friend PRISME Forum 2011-05-04
Stephen Friend PRISME Forum 2011-05-04Sage Base
 
Start Turning Data Into Actionable Insights
Start Turning Data Into Actionable InsightsStart Turning Data Into Actionable Insights
Start Turning Data Into Actionable InsightsTiffani Allen
 
Precision Medicine: Research Presentation
Precision Medicine: Research PresentationPrecision Medicine: Research Presentation
Precision Medicine: Research PresentationShelagh McLellan
 
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILM
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILMHOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILM
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILMEva Glass
 
SILS 2015 - De Hogeweyk, the Care Concept
SILS 2015 - De Hogeweyk, the Care Concept SILS 2015 - De Hogeweyk, the Care Concept
SILS 2015 - De Hogeweyk, the Care Concept Sherbrooke Innopole
 
From Clinical Decision Support to Precision Medicine
From Clinical Decision Support to Precision MedicineFrom Clinical Decision Support to Precision Medicine
From Clinical Decision Support to Precision MedicineKent State University
 
Puzzle Families
Puzzle FamiliesPuzzle Families
Puzzle Families972design
 

Viewers also liked (20)

SILS 2015 - Transforming Data into Actionable Knowledge
SILS 2015 - Transforming Data into Actionable KnowledgeSILS 2015 - Transforming Data into Actionable Knowledge
SILS 2015 - Transforming Data into Actionable Knowledge
 
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
 
RVTIC 2017: Portrait de la main d'oeuvre en TI
RVTIC 2017: Portrait de la main d'oeuvre en TIRVTIC 2017: Portrait de la main d'oeuvre en TI
RVTIC 2017: Portrait de la main d'oeuvre en TI
 
RVTIC 2017: Prendre le virage numérique...maintenant!
RVTIC 2017: Prendre le virage numérique...maintenant!RVTIC 2017: Prendre le virage numérique...maintenant!
RVTIC 2017: Prendre le virage numérique...maintenant!
 
SILS 2015 - Flanders' Care
SILS 2015 - Flanders' CareSILS 2015 - Flanders' Care
SILS 2015 - Flanders' Care
 
SILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE HealthcareSILS 2015 - Innovation at GE Healthcare
SILS 2015 - Innovation at GE Healthcare
 
Capital intellectuel – Votre entreprise est assise sur une mine d’or
Capital intellectuel – Votre entreprise est assise sur une mine d’or Capital intellectuel – Votre entreprise est assise sur une mine d’or
Capital intellectuel – Votre entreprise est assise sur une mine d’or
 
Demande de certificat d’autorisation (C.A.) MDDELCC
Demande de certificat d’autorisation (C.A.) MDDELCCDemande de certificat d’autorisation (C.A.) MDDELCC
Demande de certificat d’autorisation (C.A.) MDDELCC
 
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?
RVTIC 2017: Qu'est-ce qui vous distingue comme employeur?
 
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...
RVTIC 2017: Intelligence manufacturière - pour entreprises productives et inn...
 
RVTIC 2017: APN
RVTIC 2017: APNRVTIC 2017: APN
RVTIC 2017: APN
 
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif Terre
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif TerreRVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif Terre
RVTIC 2017: Recrutement à l'international: les bonnes pratiques, Objectif Terre
 
Stephen Friend PRISME Forum 2011-05-04
Stephen Friend PRISME Forum 2011-05-04Stephen Friend PRISME Forum 2011-05-04
Stephen Friend PRISME Forum 2011-05-04
 
Start Turning Data Into Actionable Insights
Start Turning Data Into Actionable InsightsStart Turning Data Into Actionable Insights
Start Turning Data Into Actionable Insights
 
Precision Medicine: Research Presentation
Precision Medicine: Research PresentationPrecision Medicine: Research Presentation
Precision Medicine: Research Presentation
 
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILM
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILMHOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILM
HOWTO INSTALL BUSBAR OF SMART GLASS PRIVACY FILM
 
SILS 2015 - De Hogeweyk, the Care Concept
SILS 2015 - De Hogeweyk, the Care Concept SILS 2015 - De Hogeweyk, the Care Concept
SILS 2015 - De Hogeweyk, the Care Concept
 
From Clinical Decision Support to Precision Medicine
From Clinical Decision Support to Precision MedicineFrom Clinical Decision Support to Precision Medicine
From Clinical Decision Support to Precision Medicine
 
Percepción y clasificación básica del color
Percepción y clasificación básica del color Percepción y clasificación básica del color
Percepción y clasificación básica del color
 
Puzzle Families
Puzzle FamiliesPuzzle Families
Puzzle Families
 

Similar to SILS 2015 - Connecting Precision Medicine to Precision Wellness

Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel DudleyMoving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel DudleyCityAge
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptshankjunk
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptshankjunk
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3Chiweon Kim
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24Hyung Jin Choi
 
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Philip Bourne
 
Methods to enhance the validity of precision guidelines emerging from big data
Methods to enhance the validity of precision guidelines emerging from big dataMethods to enhance the validity of precision guidelines emerging from big data
Methods to enhance the validity of precision guidelines emerging from big dataChirag Patel
 
Genomics in Society: Genomics, Preventive Medicine, and Society
Genomics in Society: Genomics, Preventive Medicine, and SocietyGenomics in Society: Genomics, Preventive Medicine, and Society
Genomics in Society: Genomics, Preventive Medicine, and SocietyLarry Smarr
 
Application of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem SolvingApplication of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem Solvingimprovemed
 
Big data approaches to healthcare systems
Big data approaches to healthcare systemsBig data approaches to healthcare systems
Big data approaches to healthcare systemsShubham Jain
 
The Deeply Quantified Self: A Case Study
The Deeply Quantified Self: A Case StudyThe Deeply Quantified Self: A Case Study
The Deeply Quantified Self: A Case StudyLarry Smarr
 
Very brief overview of AI in drug discovery
Very brief overview of AI in drug discoveryVery brief overview of AI in drug discovery
Very brief overview of AI in drug discoveryDr. Gerry Higgins
 
Patient-centric Genomics
Patient-centric GenomicsPatient-centric Genomics
Patient-centric GenomicsHee Gun Eom
 
Network medicine
Network medicineNetwork medicine
Network medicinestepano7
 
Digitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyDigitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyLarry Smarr
 
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)Hyung Jin Choi
 

Similar to SILS 2015 - Connecting Precision Medicine to Precision Wellness (20)

Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel DudleyMoving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
Moving from Big Data to Better Models of Disease and Drug Response - Joel Dudley
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.ppt
 
application_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.pptapplication_of_bioinformatics_in_various_fields.ppt
application_of_bioinformatics_in_various_fields.ppt
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
 
Bioinformatics in present and its future
Bioinformatics in present and its futureBioinformatics in present and its future
Bioinformatics in present and its future
 
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
Big Data and the Promise and Pitfalls when Applied to Disease Prevention and ...
 
Methods to enhance the validity of precision guidelines emerging from big data
Methods to enhance the validity of precision guidelines emerging from big dataMethods to enhance the validity of precision guidelines emerging from big data
Methods to enhance the validity of precision guidelines emerging from big data
 
Genomics in Society: Genomics, Preventive Medicine, and Society
Genomics in Society: Genomics, Preventive Medicine, and SocietyGenomics in Society: Genomics, Preventive Medicine, and Society
Genomics in Society: Genomics, Preventive Medicine, and Society
 
Application of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem SolvingApplication of Biomedical Informatics in Clinical Problem Solving
Application of Biomedical Informatics in Clinical Problem Solving
 
Big data approaches to healthcare systems
Big data approaches to healthcare systemsBig data approaches to healthcare systems
Big data approaches to healthcare systems
 
Use cases
Use casesUse cases
Use cases
 
The Deeply Quantified Self: A Case Study
The Deeply Quantified Self: A Case StudyThe Deeply Quantified Self: A Case Study
The Deeply Quantified Self: A Case Study
 
Very brief overview of AI in drug discovery
Very brief overview of AI in drug discoveryVery brief overview of AI in drug discovery
Very brief overview of AI in drug discovery
 
Pharmacogenomics
Pharmacogenomics Pharmacogenomics
Pharmacogenomics
 
Patient-centric Genomics
Patient-centric GenomicsPatient-centric Genomics
Patient-centric Genomics
 
Network medicine
Network medicineNetwork medicine
Network medicine
 
Digitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyDigitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism Body
 
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)
정밀의료와 다차원 의료데이터(유전자, Ehr, 국가자료, 영상, 센서-웨어러블)
 
Biomol presentacion 1
Biomol presentacion 1Biomol presentacion 1
Biomol presentacion 1
 

More from Sherbrooke Innopole

COVID-19 | Chaîne d'approvisionnement : enjeux et tendances
COVID-19 | Chaîne d'approvisionnement : enjeux et tendancesCOVID-19 | Chaîne d'approvisionnement : enjeux et tendances
COVID-19 | Chaîne d'approvisionnement : enjeux et tendancesSherbrooke Innopole
 
Point d'information | COVID-19 : reconfinement du Québec
Point d'information | COVID-19 : reconfinement du QuébecPoint d'information | COVID-19 : reconfinement du Québec
Point d'information | COVID-19 : reconfinement du QuébecSherbrooke Innopole
 
COVID-19 | Gestion de crise en temps de pandémie
COVID-19 | Gestion de crise en temps de pandémieCOVID-19 | Gestion de crise en temps de pandémie
COVID-19 | Gestion de crise en temps de pandémieSherbrooke Innopole
 
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravail
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravailCOVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravail
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravailSherbrooke Innopole
 
COVID-19 : Perspectives économiques
COVID-19 : Perspectives économiquesCOVID-19 : Perspectives économiques
COVID-19 : Perspectives économiquesSherbrooke Innopole
 
Stratégies et instruments : Marché des devises
Stratégies et instruments : Marché des devisesStratégies et instruments : Marché des devises
Stratégies et instruments : Marché des devisesSherbrooke Innopole
 
Transformation numérique des entreprises
Transformation numérique des entreprises Transformation numérique des entreprises
Transformation numérique des entreprises Sherbrooke Innopole
 
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...Sherbrooke Innopole
 
COVID-19 | Introduction à l'assurance crédit
COVID-19 | Introduction à l'assurance créditCOVID-19 | Introduction à l'assurance crédit
COVID-19 | Introduction à l'assurance créditSherbrooke Innopole
 
Le droit de refus au travail en contexte de COVID-19
Le droit de refus au travail en contexte de COVID-19Le droit de refus au travail en contexte de COVID-19
Le droit de refus au travail en contexte de COVID-19Sherbrooke Innopole
 
Design thinking / Déjeuner du GATE 1/2 – Leadeo
Design thinking / Déjeuner du GATE 1/2 – LeadeoDesign thinking / Déjeuner du GATE 1/2 – Leadeo
Design thinking / Déjeuner du GATE 1/2 – LeadeoSherbrooke Innopole
 
Design thinking / Déjeuner du GATE 1/2 – Axial
Design thinking / Déjeuner du GATE 1/2 – AxialDesign thinking / Déjeuner du GATE 1/2 – Axial
Design thinking / Déjeuner du GATE 1/2 – AxialSherbrooke Innopole
 
Sherbrooke Innopole - 10 ans de réalisations
Sherbrooke Innopole - 10 ans de réalisationsSherbrooke Innopole - 10 ans de réalisations
Sherbrooke Innopole - 10 ans de réalisationsSherbrooke Innopole
 
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situation
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situationTarifs douaniers sur l’acier et l’aluminium 2/2 | État de situation
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situationSherbrooke Innopole
 
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesures
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesuresTarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesures
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesuresSherbrooke Innopole
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...Sherbrooke Innopole
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American Biltrite
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American BiltriteMaintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American Biltrite
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American BiltriteSherbrooke Innopole
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-s
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-sMaintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-s
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-sSherbrooke Innopole
 
Robotique collaborative / Déjeuner du GATE 3/3 – STIM
Robotique collaborative / Déjeuner du GATE 3/3 – STIMRobotique collaborative / Déjeuner du GATE 3/3 – STIM
Robotique collaborative / Déjeuner du GATE 3/3 – STIMSherbrooke Innopole
 
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.org
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.orgRobotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.org
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.orgSherbrooke Innopole
 

More from Sherbrooke Innopole (20)

COVID-19 | Chaîne d'approvisionnement : enjeux et tendances
COVID-19 | Chaîne d'approvisionnement : enjeux et tendancesCOVID-19 | Chaîne d'approvisionnement : enjeux et tendances
COVID-19 | Chaîne d'approvisionnement : enjeux et tendances
 
Point d'information | COVID-19 : reconfinement du Québec
Point d'information | COVID-19 : reconfinement du QuébecPoint d'information | COVID-19 : reconfinement du Québec
Point d'information | COVID-19 : reconfinement du Québec
 
COVID-19 | Gestion de crise en temps de pandémie
COVID-19 | Gestion de crise en temps de pandémieCOVID-19 | Gestion de crise en temps de pandémie
COVID-19 | Gestion de crise en temps de pandémie
 
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravail
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravailCOVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravail
COVID-19 | Cybersécurité et d’outils de collaboration en contexte de télétravail
 
COVID-19 : Perspectives économiques
COVID-19 : Perspectives économiquesCOVID-19 : Perspectives économiques
COVID-19 : Perspectives économiques
 
Stratégies et instruments : Marché des devises
Stratégies et instruments : Marché des devisesStratégies et instruments : Marché des devises
Stratégies et instruments : Marché des devises
 
Transformation numérique des entreprises
Transformation numérique des entreprises Transformation numérique des entreprises
Transformation numérique des entreprises
 
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...
COVID-19 | Diversification de marchés en prévision de la relance, avec un reg...
 
COVID-19 | Introduction à l'assurance crédit
COVID-19 | Introduction à l'assurance créditCOVID-19 | Introduction à l'assurance crédit
COVID-19 | Introduction à l'assurance crédit
 
Le droit de refus au travail en contexte de COVID-19
Le droit de refus au travail en contexte de COVID-19Le droit de refus au travail en contexte de COVID-19
Le droit de refus au travail en contexte de COVID-19
 
Design thinking / Déjeuner du GATE 1/2 – Leadeo
Design thinking / Déjeuner du GATE 1/2 – LeadeoDesign thinking / Déjeuner du GATE 1/2 – Leadeo
Design thinking / Déjeuner du GATE 1/2 – Leadeo
 
Design thinking / Déjeuner du GATE 1/2 – Axial
Design thinking / Déjeuner du GATE 1/2 – AxialDesign thinking / Déjeuner du GATE 1/2 – Axial
Design thinking / Déjeuner du GATE 1/2 – Axial
 
Sherbrooke Innopole - 10 ans de réalisations
Sherbrooke Innopole - 10 ans de réalisationsSherbrooke Innopole - 10 ans de réalisations
Sherbrooke Innopole - 10 ans de réalisations
 
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situation
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situationTarifs douaniers sur l’acier et l’aluminium 2/2 | État de situation
Tarifs douaniers sur l’acier et l’aluminium 2/2 | État de situation
 
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesures
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesuresTarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesures
Tarifs douaniers sur l’acier et l’aluminium 1/2 | Mesures et contre-mesures
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 1/3 – Institut techno...
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American Biltrite
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American BiltriteMaintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American Biltrite
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 3/3 – American Biltrite
 
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-s
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-sMaintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-s
Maintenance industrielle à l’ère 4.0 / Déjeuner du GATE 2/3 – Exo-s
 
Robotique collaborative / Déjeuner du GATE 3/3 – STIM
Robotique collaborative / Déjeuner du GATE 3/3 – STIMRobotique collaborative / Déjeuner du GATE 3/3 – STIM
Robotique collaborative / Déjeuner du GATE 3/3 – STIM
 
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.org
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.orgRobotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.org
Robotique collaborative / Déjeuner du GATE 2/3 – IntelliLab.org
 

Recently uploaded

L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 

Recently uploaded (20)

L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 

SILS 2015 - Connecting Precision Medicine to Precision Wellness

  • 1. Connecting Precision Medicine to Precision Wellness towards a systems understanding of health and disease Joel Dudley, PhD Director of Biomedical Informatics & Associate Professor of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai @IcahnInstitute
  • 2. Mount Sinai Health System >6,000 Physicians 7 Member hospital campuses >3,500 >3,100,000 Patient visits Hospital beds
  • 3. “The future is already here — it's just not very evenly distributed”. - William Gibson
  • 4. There are rarely smoking guns in human health
  • 5. There are rarely smoking guns in human health
  • 6. No such thing as a “simple” disease Cutting GR. Nature Reviews Genetics. (2014) doi:10.1038/nrg3849 Woody Guthrie
  • 7. Complex molecular networks underlie human physiology
  • 8. We must embrace complexity to fully understand patient physiology and disease “A complex adaptive system has three characteristics. The first is that the system consists of a number of heterogeneous agents, and each of those agents makes decisions about how to behave. The most important dimension here is that those decisions will evolve over time. The second characteristic is that the agents interact with one another. That interaction leads to the third—something that scientists call emergence: In a very real way, the whole becomes greater than the sum of the parts. The key issue is that you can’t really understand the whole system by simply looking at its individual parts”. - Michael J. Mauboussin (investment banker)
  • 9.
  • 10. Icahn Institute for Genomics and Multiscale Biology
  • 11. Being masters of really big data is now critical for biomedical research (TB→PB→EB→ZB) Organisms Tissues Single cells Single cell, real-time, continuous?
  • 12. Biology’s atom smasher moment— We can measure more than we know
  • 13. Redefining the system of human disease with data ~300 Diseases and Conditions 20k+ Genes Blue: gene goes down in disease Yellow: gene goes up in disease
  • 14. Redefining the system of human disease with data Suthram S, Dudley J et al. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Computational Biology (2010) Figure 2. Significant disease-disease similarities. (A)Hierarchical clustering of thediseasecorrelations.Thedistancebetweentwo disease defined to be(1-correlation coefficient) of thetwo diseases. Thetree wasconstructed using theaverage method of hierarchical clustering. Th line corresponds to a p-value of 0.01 and FDRof 10.37%and, disease correlations below this line are considered significant. The different c
  • 15. Unexpected connection: anticonvulsant drug treats inflammatory bowel disease • TNBS chemically induced rat model of IBD • Animals treated with 80mg/kg topiramate oral after sensitization • Prednisolone positive control (approved for IBD in humans) Dudley, J. T., Sirota, M., et al. (2011). Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease. Science Translational Medicine, 3(96).
  • 16. Control Imipramine Unexpected connection: antipsychotic drug treats small cell lung cancer p53/Rb/p130 triple knockout model of SCLC Mice dosed after tumor formation
  • 17. Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015) Nature Biotechnology. in press. How do approved drugs modulate networks in immune cells?
  • 18. Antifungal activates neutrophil migration Drug A Drug B Drug A Drug A Drug B Drug A Drug B Drug A Drug B Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015) Nature Biotechnology. in press.
  • 19. Antifungal activates neutrophil migration Drug A Drug B Drug A Drug A Drug B Drug A Drug B Drug A Drug B Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015) Nature Biotechnology. in press.
  • 20. Immunemod score predicts immune cell perturbations in patient populations Kidd BA, Wroblewska A, Agudo J, Merad M, Brown BD, Dudley JT. Systematic integrative analysis of immune pharmacology. (2015) Nature Biotechnology. in press.
  • 21. Understanding the multiscale complexity of patient populations = Genomic Environment Clinical
  • 22. Capturing rich multi scale data on patients through the Mount Sinai Biobank
  • 23.
  • 25. Type 2, Type 3, and Type 4 diabetes?
  • 28.
  • 29. We are on the crest of a tsunami in consumer sensor technologies
  • 31.
  • 32.
  • 33.
  • 34. Genome function is very context dependent • eQTL • What? • Where? • When?
  • 35. Genome function is all about context
  • 36. Genome function is all about context
  • 37.
  • 38.
  • 39. 1. Drug A 2. Drug B 3. Drug C 4. Tolfenamic Acid 5. Drug D 6. Drug E 7. … SP1 NDMN Network Model Drugs perturbing SP1 sub- network towards healthy prioritized by network activity The network as the target
  • 40. Web-scale deep computing as the future of medicine and research http://www.bbc.com/news/technology-18595351
  • 41. Web-scale deep computing as the future of medicine and research Xiong et al. Science 9 January 2015
  • 42. Consumer health tools as a driver of data-driven healthcare Where will most of the health data be in 5-10 years?
  • 43. We can embrace digital health and sensors to map the human phoneme and envirome
  • 44. Electronic Consent and Patient Engagement
  • 45. Electronic Consent and Patient Engagement
  • 46. A Learning Digital Health Platform for Chronic Lung Disease
  • 47. A Learning Digital Health Platform for Chronic Lung Disease
  • 48. We need to collect “long” dynamic data for Precision Wellness
  • 49. In the future you will have coordinates instead of a diagnosis Topol EJ. Individualized Medicine from Prewomb to Tomb Cell 157, March 27, 2014
  • 50. The emergence of science- and data-driven wellness info@precisionwellness.org
  • 51. The emergence of science- and data-driven wellness info@precisionwellness.org Digital Health Molecular Profiling Data Science Clinical Medicine The Harris Center for Precision Wellness www.precisionwellness.org
  • 52.
  • 53. “The future is already here — it's just not very evenly distributed”. - William Gibson
  • 54. Email: joel.dudley@mssm.edu Twitter: @jdudley Web: dudleylab.org precisionwellness.org Icahn School of Medicine at Mount Sinai Thank you for your attention!